Primary adenocarcinoma of the lung - histological subtypes and outcome after surgery, using the IASLC/ATS/ERS classification of lung adenocarcinoma

被引:13
|
作者
Oskarsdottir, Gudrun Nina [1 ,2 ]
Bjornsson, Johannes [3 ]
Jonsson, Steinn [1 ,2 ]
Isaksson, Helgi J. [4 ]
Gudbjartsson, Tomas [2 ,5 ]
机构
[1] Landspitali Univ Hosp, Dept Pulmonol, Reykjavik, Iceland
[2] Univ Iceland, Fac Med, Reykjavik, Iceland
[3] Akureyri Hosp, Dept Pathol, Reykjavik, Iceland
[4] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland
[5] Landspitali Univ Hosp, Dept Cardiothorac Surg, Reykjavik, Iceland
关键词
Lung adenocarcinoma; histology; classification; adenocarcinoma subtypes; INTERNATIONAL-ASSOCIATION; GRADING SYSTEM; PROGNOSTIC-SIGNIFICANCE; CANCER; SURVIVAL; MUTATIONS; RECURRENCE; THERAPY; PATTERN; MARKER;
D O I
10.1111/apm.12522
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adenocarcinoma is the most common histological type of lung carcinoma. Recently the histologic classification of adenocarcinomas in the lung was modified to better reflect biologic properties and prognosis. We reviewed the histology of all primary lung adenocarcinomas operated on in Iceland during a 20-year period and assessed the impact of histology on survival. This nationwide study included 285 patients (mean age 67 years, 57% female), who underwent resection in Iceland from 1991 to 2010. Tumors were reclassified according to the current IASLC/ATS/ERS classification system. Overall survival was estimated by the Kaplan-Meier method and Cox regression analysis used to evaluate prognostic factors of overall mortality. Acinar predominant adenocarcinoma was the most common histological subtype (46%) followed by solid-predominant (SPA) with mucin production comprised (23%). Non-invasive carcinomas were rare. A difference in survival between the histological adenocarcinoma subtypes was not seen (p = 0.32) and multivariate analysis showed that advanced stage and age predicted worse outcome, but histologic subtyping of adenocarcinoma did not. In this nation-wide study there was not a statistical difference in survival according to adenocarcinoma subtypes and the histological subtype did not predict mortality. Preinvasive and minimally invasive adenocarcinomas were rare.
引用
收藏
页码:384 / 392
页数:9
相关论文
共 50 条
  • [41] Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells
    Cruz-Rico, Graciela
    Aviles-Salas, Alejandro
    Popa-Navarro, Xitlally
    Lara-Mejia, Luis
    Catalan, Rodrigo
    Sanchez-Reyes, Roberto
    Lopez-Sanchez, Dennis
    Cabrera-Miranda, Luis
    Aquiles Maldonado-Martinez, Hector
    Samtani-Bassarmal, Suraj
    Arrieta, Oscar
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [42] Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma
    Wang, Hongyan
    Zhang, Wen
    Wang, Kai
    Li, Xiaofeng
    MEDICINE, 2018, 97 (26)
  • [43] Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy
    Takahashi, Yusuke
    Eguchi, Takashi
    Bains, Sarina
    Adusumilli, Prasad S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (04)
  • [44] RELEVANCE OF THE NOVEL IASLC/ATS/ERS CLASSIFICATION OF LUNG ADENOCARCINOMA IN ADVANCED-DISEASE NON-SMALL CELL LUNG CANCER
    Campos Parra, Alma D.
    Aviles, Alejandro
    Contreras-Reyes, Susana
    Rojas Marin, Carlos
    Dominguez Malagon, Hugo
    Flores-Estrada, Diana
    Borbolla, Jose
    Arrieta, Oscar
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S967 - S967
  • [45] PREDICTING STRATIFICATION FOR RECURRENCE OF EARLY LUNG ADENOCARCINOMA BASED ON 7TH TNM CLASSIFICATION AND IASLC/ATS/ERS CLASSIFICATION
    Ito, Masaoki
    Kushitani, Kei
    Miyata, Yoshihiro
    Yoshiya, Tomoharu
    Ibuki, Yuta
    Misumi, Keizo
    Okada, Morihito
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1250 - S1250
  • [46] Discrepancy of ALK Status in Lung Adenocarcinoma Subtypes According to the IALSC/ATS/ERS Classification in Chinese Patients
    Li, Shun
    Yu, Yongfeng
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S413 - S413
  • [47] Why Do Pathological Stage IA Lung Adenocarcinomas Vary from Prognosis?: A Clinicopathologic Study of 176 Patients with Pathological Stage IA Lung Adenocarcinoma Based on the IASLC/ATS/ERS Classification
    Zhang, Jie
    Wu, Jie
    Tan, Qiang
    Zhu, Lei
    Gao, Wen
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (09) : 1196 - 1202
  • [48] Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil
    de Melo, Andreia Cristina
    de Sa, Vanessa Karen
    Sternberg, Cinthya
    Olivieri, Eloisa Ribeiro
    da Cunha, Isabela Werneck
    Fabro, Alexandre Todorovic
    Carraro, Dirce Maria
    de Barros e Silva, Milton Jose
    Pimenta Inada, Haynna Kimie
    de Mello, Evandro Sobrosa
    Soares, Fernando Augusto
    Takagaki, Tereza
    Ferreira, Carlos Gil
    Capelozzi, Vera Luiza
    ONCOLOGY, 2015, 89 (03) : 175 - 186
  • [49] Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification
    Rodriguez, Erika F.
    Dacic, Sanja
    Pantanowitz, Liron
    Khalbuss, Walid E.
    Monaco, Sara E.
    CANCER CYTOPATHOLOGY, 2015, 123 (05) : 306 - 317
  • [50] FDG PET-CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value
    Suarez-Pinera, Marina
    Belda-Sanchis, Jose
    Taus, Alvaro
    Sanchez-Font, Albert
    Mestre-Fusco, Antoni
    Jimenez, Marcel
    Pijuan, Lara
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 8 (02): : 100 - 109